NPPA and Parkinson disease: Lim et al. elaborated on the involvement of KP in PD pathogenesis where the levels of KYN metabolites altered the levels of KP metabolites in L-DOPA treated PD patients, which influenced the glutaminergic transmission resulting in L-DOPA-induced dyskinesia (LID) [15].